0001144204-11-023675.txt : 20110425 0001144204-11-023675.hdr.sgml : 20110425 20110425060204 ACCESSION NUMBER: 0001144204-11-023675 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110421 FILED AS OF DATE: 20110425 DATE AS OF CHANGE: 20110425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karkus Ted William CENTRAL INDEX KEY: 0001457896 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 11776380 MAIL ADDRESS: STREET 1: 188 HEWLETT NECK ROAD CITY: WOODMERE STATE: NY ZIP: 11598 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2153450919 MAIL ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 4 1 v219488_ex.xml X0303 4 2011-04-21 0 0000868278 ProPhase Labs, Inc. PRPH 0001457896 Karkus Ted William 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 1 1 0 0 CEO & Chaiman Common Stock, par value $0.0005 2011-04-21 4 A 0 133928 0 A 754778 D Common Stock, par value $0.0005 2011-04-21 4 A 0 128571 0 A 883349 D Common Stock, par value $0.0005 2011-04-21 4 A 0 161830 0 A 1045179 D The transaction reported in this row involves a grant of the Issuer's common stock with respect to the Reporting Person's executive bonus for services rendered in 2010. The transaction reported in this row involves the conversion of deferred compensation owed to the Reporting Person into shares of common stock. The transaction reported in this row involves a grant of restricted common stock pursuant to the terms of the Reporting Person's employment agreement, dated August 19, 2009, as amended April 21, 2011. The shares will vest in two equal installments on October 31, 2011 and June 30, 2012. The number of shares for each issuance reported in this Form 4 were determined by the Issuer's Compensation Committee based on the average closing price of the Issuer's common stock for the last five (5) trading days prior to and including the issuance date, which was equal to $1.12. /s/ Ted Karkus 2011-04-22